Advertisement
Canada markets open in 4 hours 36 minutes
  • S&P/TSX

    21,708.44
    +52.39 (+0.24%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • CAD/USD

    0.7267
    +0.0004 (+0.06%)
     
  • CRUDE OIL

    82.96
    +0.23 (+0.28%)
     
  • Bitcoin CAD

    88,733.77
    +4,235.56 (+5.01%)
     
  • CMC Crypto 200

    1,326.33
    +13.70 (+1.05%)
     
  • GOLD FUTURES

    2,397.40
    -0.60 (-0.03%)
     
  • RUSSELL 2000

    1,942.96
    -4.99 (-0.26%)
     
  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     
  • NASDAQ futures

    17,401.50
    -145.75 (-0.83%)
     
  • VOLATILITY

    19.96
    +1.96 (+10.89%)
     
  • FTSE

    7,824.08
    -52.97 (-0.67%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Stocks in play: The Yield Growth Corp.

Announced subsidiary Flourish Mushroom Labs is executing on its strategy that is strongly aligned with the growing media recognition around psilocybin research. This includes films, books and international legislative action. Netflix recently launched a new series featuring Gwyneth Paltrow called The Goop Lab, and the season kicked off with episode one focused on psilocybin and psychedelic research for health and healing. In the episode, Paltrow's team collaborated with the Multidisciplinary Association for Psychedelic Studies (MAPS). "Awareness is growing, not just here in Canada but on the international stage - driven partly by the increased media attention on all of these fronts, but ultimately by the health results that people have achieved with the support of psychedelics," said Yield Growth CEO Penny White. "The public is working to push this agenda forward, and legislators are taking notice." The Yield Growth Corp. shares BOSS:CNX are trading down 1 cent at $0.26.

Read: Actress Gwyneth Paltrow Talks Benefits of Psilocybin Mushrooms